Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 12.33M | $290.0M | 9.82% | +363.0K | 2026-03-31 |
| Frazier Life Sciences Management, L.P. | 9.87M | $232.0M | 7.86% | -- | 2026-03-31 |
| BlackRock, Inc. | 9.20M | $216.0M | 7.33% | +100.8K | 2026-03-31 |
| Rubric Capital Management LP | 8.27M | $194.0M | 6.59% | -- | 2026-03-31 |
| STATE STREET CORP | 6.30M | $148.0M | 5.01% | +807.9K | 2026-03-31 |
| Polar Capital Holdings Plc | 5.67M | $133.0M | 4.51% | +110.8K | 2026-03-31 |
| JENNISON ASSOCIATES LLC | 4.98M | $117.0M | 3.97% | -1.78M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.87M | $114.0M | 3.88% | -- | 2026-03-31 |
| GILDER GAGNON HOWE & CO LLC | 4.30M | $101.0M | 3.43% | -149.8K | 2026-03-31 |
| MORGAN STANLEY | 4.22M | $99.0M | 3.36% | -121.3K | 2026-03-31 |
